Skip to main content
Top
Published in: Journal of Translational Medicine 1/2017

Open Access 01-12-2017 | Research

Application of survival tree analysis for exploration of potential interactions between predictors of incident chronic kidney disease: a 15-year follow-up study

Authors: Azra Ramezankhani, Maryam Tohidi, Fereidoun Azizi, Farzad Hadaegh

Published in: Journal of Translational Medicine | Issue 1/2017

Login to get access

Abstract

Background

Chronic kidney disease (CKD) is a growing public health challenges worldwide. Various studies have investigated risk factors of incident CKD; however, a very few studies examined interaction between these risk factors. In an attempt to clarify the potential interactions between risk factors of CKD, we performed survival tree analysis.

Methods

A total of 8238 participants (46.1% men) aged > 20 years without CKD at baseline [(1999–2001) and (2002–2005)], were followed until 2014. The first occurrence of CKD, defined as the estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m2, was set as the main outcome. Multivariable Cox proportional hazard (Cox PH) regression was used to identify significant independent predictors of CKD; moreover, survival tree analysis was performed to gain further insight into the potential interactions between predictors.

Results

The crude incidence rates of CKD were 20.2 and 35.2 per 1000 person-years in men and women, respectively. The Cox PH identified the main effect of significant predictors of CKD incidence in men and women. In addition, using a limited number of predictors, survival trees identified 12 and 10 subgroups among men and women, respectively, with different survival probability. Accordingly, a group of men with eGFR > 74 ml/min/1.73 m2, age ≤ 46 years, low level of physical activity, waist circumference ≤ 100 cm and FPG ≤ 4.7 mmol/l had the lowest risk of CKD incidence; while men with eGFR ≤ 63.4 ml/min/1.73 m2, age > 50 years had the highest risk for CKD compared to men in the lowest risk group [hazard ratio (HR), 70.68 (34.57–144.52)]. Also, a group of women aged ≤ 45 years and eGFR > 83.5 ml/min/1.73 m2 had the lowest risk; while women with age > 48 years and eGFR ≤ 69 ml/min/1.73 m2 had the highest risk compared to low risk group [HR 27.25 (19.88–37.34)].

Conclusion

In this post hoc analysis, we found the independent predictors of CKD using Cox PH; furthermore, by applying survival tree analysis we identified several numbers of homogeneous subgroups with different risk for incidence of CKD. Our study suggests that two methods can be used simultaneously to provide new insights for intervention programs and improve clinical decision making.
Literature
1.
go back to reference Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–72.CrossRefPubMed Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–72.CrossRefPubMed
2.
go back to reference Tsai W-C, Wu H-Y, Peng Y-S, Ko M-J, Wu M-S, Hung K-Y, et al. Risk factors for development and progression of chronic kidney disease: a systematic review and exploratory meta-analysis. Medicine. 2016;95(11):e3013.CrossRefPubMedPubMedCentral Tsai W-C, Wu H-Y, Peng Y-S, Ko M-J, Wu M-S, Hung K-Y, et al. Risk factors for development and progression of chronic kidney disease: a systematic review and exploratory meta-analysis. Medicine. 2016;95(11):e3013.CrossRefPubMedPubMedCentral
3.
go back to reference Ramirez-Rubio O, McClean MD, Amador JJ, Brooks DR. An epidemic of chronic kidney disease in Central America: an overview. Postgrad Med J. 2013;89(1049):123–5.CrossRefPubMed Ramirez-Rubio O, McClean MD, Amador JJ, Brooks DR. An epidemic of chronic kidney disease in Central America: an overview. Postgrad Med J. 2013;89(1049):123–5.CrossRefPubMed
4.
go back to reference Radhakrishnan J, Remuzzi G, Saran R, Williams DE, Rios-Burrows N, Powe N, et al. Taming the chronic kidney disease epidemic: a global view of surveillance efforts. Kidney Int. 2014;86(2):246–50.CrossRefPubMedPubMedCentral Radhakrishnan J, Remuzzi G, Saran R, Williams DE, Rios-Burrows N, Powe N, et al. Taming the chronic kidney disease epidemic: a global view of surveillance efforts. Kidney Int. 2014;86(2):246–50.CrossRefPubMedPubMedCentral
5.
go back to reference Mangione F, Canton AD. The epidemic of chronic kidney disease: looking at ageing and cardiovascular disease through kidney-shaped lenses. J Intern Med. 2010;268(5):449–55.CrossRefPubMed Mangione F, Canton AD. The epidemic of chronic kidney disease: looking at ageing and cardiovascular disease through kidney-shaped lenses. J Intern Med. 2010;268(5):449–55.CrossRefPubMed
6.
go back to reference Herget-Rosenthal S, Dehnen D, Kribben A, Quellmann T. Progressive chronic kidney disease in primary care: modifiable risk factors and predictive model. Prev Med. 2013;57(4):357–62.CrossRefPubMed Herget-Rosenthal S, Dehnen D, Kribben A, Quellmann T. Progressive chronic kidney disease in primary care: modifiable risk factors and predictive model. Prev Med. 2013;57(4):357–62.CrossRefPubMed
7.
go back to reference McClellan WM, Ramirez SP, Jurkovitz C. Screening for chronic kidney disease: unresolved issues. J Am Soc Nephrol. 2003;14(suppl 2):81–7.CrossRef McClellan WM, Ramirez SP, Jurkovitz C. Screening for chronic kidney disease: unresolved issues. J Am Soc Nephrol. 2003;14(suppl 2):81–7.CrossRef
8.
go back to reference Johnson RA, Wichern DW. Applied multivariate statistical analysis. Upper Saddle River: Prentice hall; 2002. Johnson RA, Wichern DW. Applied multivariate statistical analysis. Upper Saddle River: Prentice hall; 2002.
9.
go back to reference Kleinbaum DG, Klein M. Logistic regression: a self-learning text. 3rd ed. New York: Springer; 2010.CrossRef Kleinbaum DG, Klein M. Logistic regression: a self-learning text. 3rd ed. New York: Springer; 2010.CrossRef
10.
go back to reference Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMC Med. 2015;13(1):1.CrossRefPubMedPubMedCentral Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMC Med. 2015;13(1):1.CrossRefPubMedPubMedCentral
11.
go back to reference Zhang H, Singer B. Recursive partitioning and applications. Berlin: Springer Science & Business Media; 2010.CrossRef Zhang H, Singer B. Recursive partitioning and applications. Berlin: Springer Science & Business Media; 2010.CrossRef
12.
go back to reference Su S-L, Lin C, Kao S, et al. Risk factors and their interaction on chronic kidney disease: a multi-centre case control study in Taiwan. BMC Nephrol. 2015;16(16):83.CrossRefPubMedPubMedCentral Su S-L, Lin C, Kao S, et al. Risk factors and their interaction on chronic kidney disease: a multi-centre case control study in Taiwan. BMC Nephrol. 2015;16(16):83.CrossRefPubMedPubMedCentral
13.
go back to reference Liu W-C, Hung C-C, Chen S-C, et al. Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality. Clin J Am Soc Nephrol. 2012;7(4):541–8.CrossRefPubMed Liu W-C, Hung C-C, Chen S-C, et al. Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality. Clin J Am Soc Nephrol. 2012;7(4):541–8.CrossRefPubMed
14.
go back to reference Loh WY. Fifty years of classification and regression trees. Int Stat Rev. 2014;82(3):329–48.CrossRef Loh WY. Fifty years of classification and regression trees. Int Stat Rev. 2014;82(3):329–48.CrossRef
15.
go back to reference Ramezankhani A, Pournik O, Shahrabi J, Khalili D, Azizi F, Hadaegh F. Applying decision tree for identification of a low risk population for type 2 diabetes. Tehran Lipid and Glucose Study. Diabetes Res Clin Pract. 2014;105(3):391–8.CrossRefPubMed Ramezankhani A, Pournik O, Shahrabi J, Khalili D, Azizi F, Hadaegh F. Applying decision tree for identification of a low risk population for type 2 diabetes. Tehran Lipid and Glucose Study. Diabetes Res Clin Pract. 2014;105(3):391–8.CrossRefPubMed
18.
go back to reference Parizadeh D, Ramezankhani A, Momenan AA, Azizi F, Hadaegh F. Exploring risk patterns for incident ischemic stroke during more than a decade of follow-up: a survival tree analysis. Comput Methods Programs Biomed. 2017;147:29–36.CrossRefPubMed Parizadeh D, Ramezankhani A, Momenan AA, Azizi F, Hadaegh F. Exploring risk patterns for incident ischemic stroke during more than a decade of follow-up: a survival tree analysis. Comput Methods Programs Biomed. 2017;147:29–36.CrossRefPubMed
20.
go back to reference Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10:5.CrossRefPubMedPubMedCentral Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10:5.CrossRefPubMedPubMedCentral
21.
go back to reference Hosseinpanah F, Kasraei F, Nassiri AA, Azizi F. High prevalence of chronic kidney disease in Iran: a large population-based study. BMC Public Health. 2009;9:44.CrossRefPubMedPubMedCentral Hosseinpanah F, Kasraei F, Nassiri AA, Azizi F. High prevalence of chronic kidney disease in Iran: a large population-based study. BMC Public Health. 2009;9:44.CrossRefPubMedPubMedCentral
22.
go back to reference Ainsworth BE, Jacobs DR Jr, Leon AS. Validity and reliability of self-reported physical activity status: the Lipid Research Clinics questionnaire. Med Sci Sports Exerc. 1993;25(1):92–8.CrossRefPubMed Ainsworth BE, Jacobs DR Jr, Leon AS. Validity and reliability of self-reported physical activity status: the Lipid Research Clinics questionnaire. Med Sci Sports Exerc. 1993;25(1):92–8.CrossRefPubMed
23.
go back to reference Mirmiran Mohammadi, Allahverdian Azizi. Estimation of energy requirements for adults: Tehran Lipid and Glucose Study. Int J Vitam Nutr Res. 2003;73(3):193–200.CrossRefPubMed Mirmiran Mohammadi, Allahverdian Azizi. Estimation of energy requirements for adults: Tehran Lipid and Glucose Study. Int J Vitam Nutr Res. 2003;73(3):193–200.CrossRefPubMed
24.
25.
go back to reference Momenan AA, Delshad M, Sarbazi N, Rezaei Ghaleh N, Ghanbarian A, Azizi F. Reliability and validity of the modifiable activity questionnaire (MAQ) in an Iranian urban adult population. Arch Iran Med. 2012;15(5):279–82.PubMed Momenan AA, Delshad M, Sarbazi N, Rezaei Ghaleh N, Ghanbarian A, Azizi F. Reliability and validity of the modifiable activity questionnaire (MAQ) in an Iranian urban adult population. Arch Iran Med. 2012;15(5):279–82.PubMed
26.
go back to reference Levey ASEK, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089–100.CrossRefPubMed Levey ASEK, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089–100.CrossRefPubMed
27.
go back to reference World Health Organization. Guidelines for controlling and monitoring the tobacco epidemic. Geneva: World Health Organization; 1998. World Health Organization. Guidelines for controlling and monitoring the tobacco epidemic. Geneva: World Health Organization; 1998.
28.
go back to reference Jeon CY, Lokken RP, Hu FB, Van Dam RM. Physical activity of moderate intensity and risk of type 2 diabetes a systematic review. Diabetes Care. 2007;30(3):744–52.CrossRefPubMed Jeon CY, Lokken RP, Hu FB, Van Dam RM. Physical activity of moderate intensity and risk of type 2 diabetes a systematic review. Diabetes Care. 2007;30(3):744–52.CrossRefPubMed
29.
go back to reference Hothorn T, Everitt BS. A handbook of statistical analyses using R. Boca Raton: CRC Press; 2014. Hothorn T, Everitt BS. A handbook of statistical analyses using R. Boca Raton: CRC Press; 2014.
30.
go back to reference Hippisley-Cox J, Coupland C. Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney® Scores. BMC Fam Pract. 2010;11:49.CrossRefPubMedPubMedCentral Hippisley-Cox J, Coupland C. Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney® Scores. BMC Fam Pract. 2010;11:49.CrossRefPubMedPubMedCentral
31.
go back to reference Harati H, Hadaegh F, Saadat N, Azizi F. Population-based incidence of type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health. 2009;9:186.CrossRefPubMedPubMedCentral Harati H, Hadaegh F, Saadat N, Azizi F. Population-based incidence of type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health. 2009;9:186.CrossRefPubMedPubMedCentral
33.
go back to reference Imai E, Horio M, Watanabe T, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13(6):621–30.CrossRefPubMed Imai E, Horio M, Watanabe T, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13(6):621–30.CrossRefPubMed
34.
go back to reference Lucove J, Vupputuri S, Heiss G, North K, Russell M. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study. Am J Kidney Dis. 2008;51(1):21–8.CrossRefPubMed Lucove J, Vupputuri S, Heiss G, North K, Russell M. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study. Am J Kidney Dis. 2008;51(1):21–8.CrossRefPubMed
35.
go back to reference Schaeffner ES, Kurth T, Curhan GC, et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol. 2003;14(8):2084–91.PubMed Schaeffner ES, Kurth T, Curhan GC, et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol. 2003;14(8):2084–91.PubMed
36.
go back to reference Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291(7):844–50.CrossRefPubMed Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291(7):844–50.CrossRefPubMed
37.
go back to reference Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71(2):159–66.CrossRefPubMed Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71(2):159–66.CrossRefPubMed
38.
go back to reference Hossain MP, Goyder EC, Rigby JE, El Nahas M. CKD and poverty: a growing global challenge. Am J Kidney Dis. 2009;53(1):166–74.CrossRefPubMed Hossain MP, Goyder EC, Rigby JE, El Nahas M. CKD and poverty: a growing global challenge. Am J Kidney Dis. 2009;53(1):166–74.CrossRefPubMed
39.
go back to reference World Health Organization. Population nutrient intake goals for preventing diet-related chronic diseases. Geneva: World Health Organization; 2003. World Health Organization. Population nutrient intake goals for preventing diet-related chronic diseases. Geneva: World Health Organization; 2003.
40.
go back to reference Xia J, Wang L, Ma Z, Zhong L, Wang Y, Gao Y, et al. Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Nephrol Dial Transplant. 2017;32(3):475–87.CrossRefPubMed Xia J, Wang L, Ma Z, Zhong L, Wang Y, Gao Y, et al. Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Nephrol Dial Transplant. 2017;32(3):475–87.CrossRefPubMed
41.
42.
43.
go back to reference Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimbürger O, Massy Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol. 2008;3(2):505–21.CrossRefPubMed Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimbürger O, Massy Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol. 2008;3(2):505–21.CrossRefPubMed
44.
go back to reference Glassock RJ. Con: thresholds to define chronic kidney disease should not be age dependent. Nephrol Dial Transplant. 2014;29(4):774–9.CrossRefPubMed Glassock RJ. Con: thresholds to define chronic kidney disease should not be age dependent. Nephrol Dial Transplant. 2014;29(4):774–9.CrossRefPubMed
45.
go back to reference Winearls DO. Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc. 2009;120:419–28.PubMedPubMedCentral Winearls DO. Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc. 2009;120:419–28.PubMedPubMedCentral
46.
go back to reference Esteghamati A, Abbasi M, Alikhani S, Gouya MM, Delavari A, Shishehbor MH, et al. Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: the national survey of risk factors for noncommunicable diseases of Iran. Am J Hypertens. 2008;21(6):620–6.CrossRefPubMed Esteghamati A, Abbasi M, Alikhani S, Gouya MM, Delavari A, Shishehbor MH, et al. Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: the national survey of risk factors for noncommunicable diseases of Iran. Am J Hypertens. 2008;21(6):620–6.CrossRefPubMed
47.
go back to reference Hadaegh F, Derakhshan A, Zafari N, Khalili D, Mirbolouk M, Saadat N, et al. Pre-diabetes tsunami: incidence rates and risk factors of pre-diabetes and its different phenotypes over 9 years of follow-up. Diabet Med. 2017;34(1):69–78.CrossRefPubMed Hadaegh F, Derakhshan A, Zafari N, Khalili D, Mirbolouk M, Saadat N, et al. Pre-diabetes tsunami: incidence rates and risk factors of pre-diabetes and its different phenotypes over 9 years of follow-up. Diabet Med. 2017;34(1):69–78.CrossRefPubMed
49.
go back to reference Sawada S, Yamashita N, Suehisa H, Yamashita M. Risk factors for recurrence after lung cancer resection as estimated using the survival tree method. Chest. 2013;144(4):1238–44.CrossRefPubMed Sawada S, Yamashita N, Suehisa H, Yamashita M. Risk factors for recurrence after lung cancer resection as estimated using the survival tree method. Chest. 2013;144(4):1238–44.CrossRefPubMed
50.
go back to reference Ali RA, Dooley C, Comber H, Newell J, Egan LJ. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease. Clin Gastroenterol Hepatol. 2011;9(7):584–9.CrossRefPubMed Ali RA, Dooley C, Comber H, Newell J, Egan LJ. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease. Clin Gastroenterol Hepatol. 2011;9(7):584–9.CrossRefPubMed
51.
go back to reference Vistisen D, Andersen GS, Hansen CS, Hulman A, Henriksen JE, Bech-Nielsen H, et al. Prediction of first cardiovascular disease event in type 1 diabetes: the steno T1 risk engine. Circulation. 2016;133(11):1058–66.CrossRefPubMed Vistisen D, Andersen GS, Hansen CS, Hulman A, Henriksen JE, Bech-Nielsen H, et al. Prediction of first cardiovascular disease event in type 1 diabetes: the steno T1 risk engine. Circulation. 2016;133(11):1058–66.CrossRefPubMed
52.
go back to reference Zhou Y, McArdle JJ. Rationale and applications of survival tree and survival ensemble methods. Psychometrika. 2015;80(3):811–33.CrossRefPubMed Zhou Y, McArdle JJ. Rationale and applications of survival tree and survival ensemble methods. Psychometrika. 2015;80(3):811–33.CrossRefPubMed
53.
go back to reference Hothorn T, Hornik K, Zeileis A. Unbiased recursive partitioning: a conditional inference framework. J Comput Graph Stat. 2006;15(3):651–74.CrossRef Hothorn T, Hornik K, Zeileis A. Unbiased recursive partitioning: a conditional inference framework. J Comput Graph Stat. 2006;15(3):651–74.CrossRef
54.
go back to reference Lunyera J, Mohottige D, Von Isenburg M, et al. CKD of uncertain etiology: a systematic review. Clin J Am Soc Nephrol. 2016;11(3):379–85.CrossRefPubMed Lunyera J, Mohottige D, Von Isenburg M, et al. CKD of uncertain etiology: a systematic review. Clin J Am Soc Nephrol. 2016;11(3):379–85.CrossRefPubMed
55.
go back to reference Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127(8 Pt 2):757–63.CrossRefPubMed Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127(8 Pt 2):757–63.CrossRefPubMed
56.
go back to reference Epping-Jordan JE, Galea G, Tukuitonga C, Beaglehole R. Preventing chronic diseases: taking stepwise action. Lancet. 2005;366(9497):1667–71.CrossRefPubMed Epping-Jordan JE, Galea G, Tukuitonga C, Beaglehole R. Preventing chronic diseases: taking stepwise action. Lancet. 2005;366(9497):1667–71.CrossRefPubMed
Metadata
Title
Application of survival tree analysis for exploration of potential interactions between predictors of incident chronic kidney disease: a 15-year follow-up study
Authors
Azra Ramezankhani
Maryam Tohidi
Fereidoun Azizi
Farzad Hadaegh
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2017
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-017-1346-x

Other articles of this Issue 1/2017

Journal of Translational Medicine 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.